FK506 promotes functional recovery in crushed rat sciatic nerve

Muscle and Nerve

Volumn 23, Issue 4, 2000, Pages 633-640

  Lee, Michelle ^a   Doolabh, Vaishali B ^a   Mackinnon, Susan E ^a   Jost, Sarah ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axonotmetic injury; Blood nerve barrier; Cyclosporin A; FK506; Nerve regeneration

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FUNCTIONAL ASSESSMENT; MALE; MORPHOMETRICS; NERVE CRUSH; NERVE REGENERATION; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANALYSIS OF VARIANCE; ANIMALS; CYCLOSPORINE; MALE; MOTOR ACTIVITY; NERVE CRUSH; PARALYSIS; RATS; RATS, INBRED BUF; SCIATIC NERVE; TACROLIMUS; TIBIAL NERVE; TIME FACTORS;

EID: 0034022271     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(200004)23:4<633::AID-MUS24>3.0.CO;2-Q     Document Type: Article

References (23)

1. Bain JR, Mackinnon SE, Hudson AR, Falk RE, Falk JA, Hunter DA. The peripheral nerve allograft: an assessment of regeneration across nerve allografts in rats immunosuppressed with Cyclosporin A. Plast Reconstr Surg 1988;82:1052-1064.
2. Bain JR, Mackinnon SE, Hudson AR, Falk RE, Falk JA, Hunter DA. The peripheral nerve allograft: a dose-response curve in the rat immunosuppressed with Cyclosporin A. Plast Reconstr Surg 1988;82:447-455.
3. Bouldin TW, Earnhardt TS, Goines ND. Restoration of blood-nerve barrier in neuropathy is associated with axonal regeneration and remyelination. J Neuropathol Exp Neurol 1991;50:719-728.
4. Bridge PM, Ball D, Mackinnon Se, Nakao Y, Brandt K, Hunter DA, Hertl C. Nerve crush injuries - a model tor axonotmesis. Exp Neurol 1994;127:284-290.
5. Buffo A, Holtmaat AJDG, Savio T, Verbeek JS, Oberdick J, Oestreicher AB, Gispen WH, Verhaagen J, Rossi F, Strata P. Targeted overexpression of the neurite growth-associated protein B-50/GAP-13 in cerebellar Purkinje cells induces sprouting after axotomy but not axon regeneration into growth permissive transplants. J Neurosci 1997;15:8778-8791.
6. Dawson TM, Steiner JP, Lyons WE, Fotuhi M, Blue M, Snyder SH. The immunophilins, FK505 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin. Neuroscience 1994;62:569-580.
7. Gold BG, Densmore V, Shou W, Matzuk MM, Gordon HS. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J Pharmacol Exp Ther 1999;289:1202-1210.
8. Gold BG, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J Neurosci 1995;15:7509-7516.
9. Gold BG, Zeleny-Pooky M, Wang M-S, Chaturvedi P, Armistead DM. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. Exp Neurol 1997;147:269-278
10. Hare G, Evans P, Mackinnon S, Best T, Midha R, Szalai J, Hunter DA. Walking track analysis: utilization of individual footprint parameters. Ann Plast Surg 1993;30:147-153.
11. Harvey GK, Gold R, Hartung HP, Toyka KV. Non-neural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy. Brain 1995;118:1263-1272.
12. Jung S, Toyka K, Hartung HP. T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies. Brain 1996;119: 1079-1090.
13. Kobayashi J, Mackinnon SE, Watanabe O, Ball DJ, Gu XM, Hunter DA, Kuzon WM. The effect of duration of muscle denervation of functional recovery in the rat model. Muscle Nerve 1997;20:858-866.
14. Schreiber SL, Crabtree GR. The mechanism of action of Cyclosporin A and FK506. Immunol Today 1992;13:136-142.
15. Shapiro R, Fung JJ, Jain AB, Parks P, Todo S, Starzl TE. The side effects of FK506 in humans. Transplant Proc 1990;22: 35-36.
16. Spies JM, Westland KW, Bonner JG, Pollard JD. Intraneural activated T cells cause focal breakdown of the blood nerve barrier. Brain 1995;118:857-868.
17. Starzl TE, Todo S, Fung J, Demetris AJ, Venkaramman R, Jain A. FK506 for liver, kidney and pancreas transplantation. Lancet 1989;ii:1000-1004.
18. Steiner JP, Connolly MA, Valentine HL, Hamilton GS, Dawson TM, Hester L, Snyder SH. Neurotrophic actions of nonimmunosuppressive ligands of immunophilins. Nature Med 1997;3:1-8.
19. Steiner JP, Hamilton GS, Ross DT, Valentine HL, Guo H, Connolly MA, Liang S, Ramsey C, Li J, Hunag W, Howorth P, Soni R, Fuller M, Sauer H, Nowotnik AC, Suzdak PD. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci USA 1997;94:2019-2024.
20. Strettmalter SM, Igarashi M, Fishman MC. Gap 43 amino terminal peptides modulate growth cone morphology and neurite outgrowth. J Neurosci 1994;14:5503-5513.
21. Sunderland S. Classification of peripheral nerve injuries producing loss of function. Brain 1951;74:491-516.
22. Wang MS, Zeleny-Pooley M, Gold BG. Comparative dose-dependency study of FK506 and Cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J Pharmacol Exp Ther 1997;282:1084-1093.
23. Zalewski AA, Kadota Y, Azzam NA, Azzam RN. Observations on the blood and perineurial permeability barriers of surviving nerve allografts in immunodeficient and immunosuppressed rats. J Neurosurg 1993;78:794-806.